Literature DB >> 26338064

[A 65-year-old man with wearable cardioverter/defibrillator early after acute myocardial infarction].

F W Horlbeck1, G Nickenig, J O Schwab.   

Abstract

A 65-year-old man with severe coronary artery disease and coronary artery bypass graft presented with an acute posterior ST-elevation myocardial infarction. Immediate percutaneous coronary intervention resulted in successful revascularisation of the culprit lesion (RCx) with several remaining coronary stenoses. Despite the reduced left ventricular ejection fraction, no primary prevention indication for an implantable cardioverter/defibrillator early after myocardial infarction existed. Due to the complex coronary anatomy with several remaining stenotic vessels we regarded the patient to be at a particularly high risk for lethal ventricular arrhythmias and provided him with a wearable cardioverter defibrillator (WCD). Twenty-six days later, he experienced spontaneous ventricular tachycardia and fibrillation which was successfully treated with high voltage therapy by the WCD. Subsequently, we decided to implant him an ICD following secondary prevention indication. Besides established indications for primary prevention ICD therapy, some patients early after myocardial infarction may be at a particularly high risk for sudden cardiac death. Temporary protection with a WCD in carefully selected patients can offer a safe opportunity for later reevaluation of permanent ICD implantation depending on the course of left ventricular ejection fraction and the occurrence of arrhythmia.

Entities:  

Mesh:

Year:  2015        PMID: 26338064     DOI: 10.1007/s00108-015-3782-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  11 in total

1.  Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.

Authors:  Edoardo Gronda; Robert C Bourge; Maria Rosa Costanzo; Mario Deng; Donna Mancini; Luigi Martinelli; Guillermo Torre-Amione; Mary Lou O'Hara; Susan Chambers
Journal:  J Heart Lung Transplant       Date:  2006-09       Impact factor: 10.247

2.  Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA).

Authors:  Bruce L Wilkoff; Charles J Love; Charles L Byrd; Maria Grazia Bongiorni; Roger G Carrillo; George H Crossley; Laurence M Epstein; Richard A Friedman; Charles E H Kennergren; Przemyslaw Mitkowski; Raymond H M Schaerf; Oussama M Wazni
Journal:  Heart Rhythm       Date:  2009-05-22       Impact factor: 6.343

3.  Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.

Authors:  Tanyanan Tanawuttiwat; Juan D Garisto; Arturo Salow; Joann M Glad; Steve Szymkiewicz; Heath E Saltzman; Steven P Kutalek; Roger G Carrillo
Journal:  Pacing Clin Electrophysiol       Date:  2013-12-03       Impact factor: 1.976

Review 4.  Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD).

Authors:  Helmut U Klein; Ulf Meltendorf; Sven Reek; Jan Smid; Sebastian Kuss; Iwona Cygankiewicz; Christian Jons; Steven Szymkiewicz; Frank Buhtz; Anke Wollbrueck; Wojciech Zareba; Arthur J Moss
Journal:  Pacing Clin Electrophysiol       Date:  2009-11-02       Impact factor: 1.976

5.  Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival.

Authors:  Mina K Chung; Steven J Szymkiewicz; Mingyuan Shao; Edwin Zishiri; Mark J Niebauer; Bruce D Lindsay; Patrick J Tchou
Journal:  J Am Coll Cardiol       Date:  2010-07-13       Impact factor: 24.094

Review 6.  Wearable cardioverter-defibrillators.

Authors:  Arnon Adler; Amir Halkin; Sami Viskin
Journal:  Circulation       Date:  2013-02-19       Impact factor: 29.690

7.  Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT).

Authors:  Paul Dorian; Stefan H Hohnloser; Kevin E Thorpe; Robin S Roberts; Karl-Heinz Kuck; Michael Gent; Stuart J Connolly
Journal:  Circulation       Date:  2010-12-06       Impact factor: 29.690

8.  Defibrillator implantation early after myocardial infarction.

Authors:  Gerhard Steinbeck; Dietrich Andresen; Karlheinz Seidl; Johannes Brachmann; Ellen Hoffmann; Dariusz Wojciechowski; Zdzisława Kornacewicz-Jach; Beata Sredniawa; Géza Lupkovics; Franz Hofgärtner; Andrzej Lubinski; Mårten Rosenqvist; Alphonsus Habets; Karl Wegscheider; Jochen Senges
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

9.  Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.

Authors:  Andrew E Epstein; William T Abraham; Nicole R Bianco; Karl B Kern; Michael Mirro; Sunil V Rao; Edward K Rhee; Scott D Solomon; Steven J Szymkiewicz
Journal:  J Am Coll Cardiol       Date:  2013-07-31       Impact factor: 24.094

Review 10.  Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.

Authors:  Helmut U Klein; Ilan Goldenberg; Arthur J Moss
Journal:  Eur Heart J       Date:  2013-05-31       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.